BioTech/Drugs - South San Francisco, CA, US
iPierian is a biotechnology company targeting secreted Tau for treatment of Alzheimer's disease and other Tauopathies. The company's lead drug candidate (IPN007) is a monoclonal antibody targeting a novel form of secreted Tau that is differentially regulated in Alzheimer's disease patients, designed to slow the spread of Tau throughout the brain and therefore inhibit the associated disease progression.
Cloudflare DNS
CloudFlare Hosting